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Background: Evidence regarding the risk of coronavirus disease (COVID-19) and the major adverse
clinical outcomes of COVID-19 among people with disabilities (PwDs) is scarce.
Objective: This study investigated the association of disability status with the risk of severe acute res-
piratory syndrome coronavirus 2 (SARS-CoV-2) test positivity and the risk of major adverse clinical
outcomes among participants who tested positive for SARS-CoV-2.
Methods: This study included all patients (n ¼ 8070) who tested positive for SARS-CoV-2 and individuals
without COVID-19 (n ¼ 121,050) in South Korea from January 1 to May 30, 2020. The study variables
included officially registered disability status from the government, SARS-CoV-2 test positivity, and
major adverse clinical outcomes of COVID-19 (admission to the intensive care unit, invasive ventilation,
or death).
Results: The study participants included 129,120 individuals (including 7261 PwDs), of whom 8070
(6.3%) tested positive for SARS-CoV-2. After adjusting for potential confounding factors, PwDs had an
increased risk of SARS-CoV-2 test positivity compared with people without disabilities (odds ratio [OR]:
1.36, 95% confidence interval [CI]: 1.24e1.48). Among participants who tested positive for SARS-CoV-2,
PwDs were associated with an increased risk of major adverse clinical outcomes from COVID-19
compared to those without disabilities (OR: 1.43, 95% CI: 1.11e1.86).
Conclusions: PwDs had an increased risk of COVID-19 and major adverse clinical outcomes of COVID-19
compared with people without disabilities. Given the higher vulnerability of PwDs to COVID-19, tailored
policy and management to protect against the risk of COVID-19 are required.
© 2021 Elsevier Inc. All rights reserved.Introduction
Globally, there were 115.7 million confirmed cases of corona-
virus disease (COVID-19) by March 07, 2020, including 2.6 million
deaths according to World Health Organization, and the spread of
COVID-19 is predicted to increase worldwide.1 Various risk factors
for infection and severe outcomes of COVID-19 have been investi-
gated.2,3 However, the wide-ranging effect of the COVID-19
pandemic on people with disabilities (PwDs) has receivedinistration, Graduate School
a.relatively little attention, and the development of evidence-based
guidelines on COVID-19 for PwDs are lagging behind and are be-
ing given lower priority than those for people without disabilities.4
Disability is a lack or restriction of ability to perform an activity in
any domain of life.5 Approximately 15% of the world's population is
estimated to live with some form of disability6 and the number of
registered PwDs in South Korea has increased (from 1,134,177 in
2001 to 2,585,876 in 2018), which accounts for approximately 5% of
the total population.7 Given the vulnerability of PwDs to COVID-19
due to their physical or mental impairments, the right of this
population to be protected from COVID-19, and the increasing
number of PwDs due to population aging and a global increase in
the prevalence of chronic health conditions,8 there is a need to
investigate the risk of COVID-19 among PwDs.
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teristics with the incidence of COVID-19 and death using the U.S.
regional data9e11; however, personal data, such as sex, age, and
chronic diseases, were not considered in these studies. Therefore,
no evidence regarding the association between disability charac-
teristics with COVID-19 incidence and death was found using per-
sonal data. Other previous studies have examined trends in COVID-
19 and COVID-19-related deaths among people with intellectual
and developmental disabilities.12e14 However, they included only a
few types of disability and did not consider potential confounding
factors, such as underlying comorbidities. In other words, there is
no evidence for the association between disability status and risk of
COVID-19. It is necessary to examine the association between
disability status, including all types, and risk of COVID-19, after
controlling individual characteristics.
This study assessed the association between disability status
and risk of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) test positivity among all study participants. This study also
investigated the relationship between disability status and risk of
major adverse clinical outcomes (admission to the intensive care
unit, invasive ventilation, or death) among participants who tested
positive for SARS-CoV-2.
Methods
Data source and participants
This study used national data from the Korean National Health
Insurance Service (NHIS), which provides mandatory health in-
surance for all Korean citizens. As Korea has a single-payer national
health system, the NHIS has all insured individuals’ demographic
information (e.g., sex, age, household income, residential area,
disability status); all medical records regarding diagnoses, treat-
ments, and prescribed drugs; and death information.15 The Korea
Centers for Disease Control and Prevention (KCDC) database has
epidemiological information on all individuals who have been
tested for SARS-CoV-2, and the information on SARS-CoV-2 test
results in the KCDC dataset is linked to the NHIS database.16
The NHIS provided data on all patients who tested positive for
SARS-CoV-2 between January 1 and May 30, 2020. The NHIS also
provided data on comparison groups from the general population
who did not test for SARS-CoV-2 during the same period. Among
the general population, the comparison group was selected based
on characteristics for sex, age, and residential area similar to those
of the patients who tested positive for SARS-CoV-2 using simple
stratified sampling. This study included 8070 patients who tested
positive for SARS-CoV-2 and 121,050 controls.
Measures
This study used information on disability status as assessed by
physicians and officially registered by the national government. For
an individual to be registered as disabled, they needed to submit
documents, including the diagnosis established by a physician, to a
local National Pension Service office, which then notifies the
applicant of the results, including the registered type and grade of
the disability.17 The severity of disability is classified asmild (grades
4e6) or severe (grades 1e3) on the basis of functional losses and
clinical impairment. Mild disability was defined as the ability to
perform some daily tasks independently even though there may be
a partial need for assistive devices or personal assistance. Severe
disability was defined as increased dependence on assistive devices
or personal assistance. The National Pension Service categorizes
disabilities into 15 types, which include physical disability,
disability due to brain injury, visual disability, hearing disability,2
speech and language disability, intellectual disability, disability due
to mental disorder, speech and language disability, and disability
due to autism spectrum disorder, heart problems, respiratory
problems, liver disease, facial disfigurement, excretory problems,
and epilepsy.
The primary outcome in this study was SARS-CoV-2 test posi-
tivity among all study participants. The secondary outcome was
major adverse clinical outcomes of COVID-19, which comprised
admission to the intensive care unit, invasive ventilation, or death.
The potentially confounding factors included sex, age, residen-
tial area, household income, and comorbidities. During the initial
epidemic period in South Korea, there was an explosive outbreak of
COVID-19 in the Daegu and Gyeongbuk regions18; therefore, study
participants were categorized as living in Daegu and Gyeongbuk or
other regions. Household income was divided into quintiles. A
history of diabetes mellitus (E10e14), hypertension (I10e15), dys-
lipidemia (E78), ischemic heart disease (I20e25), stroke (I60e63),
chronic kidney disease (N18), chronic obstructive pulmonary dis-
ease (J43eJ44, except J430), asthma (J45eJ46), cancer (C00e97),
mental illness (F00e99), and chronic liver disease (K704, K711,
K713eK715, K721, K73, K743, K767eK769) were confirmed by the
reporting of at least two claims within 1 year during the 3-year
period before COVID-19 outbreak using the International Classifi-
cation of Disease, Tenth Revision code.19
Statistical analysis
First, sociodemographic and clinical characteristics of all study
participants were compared according to disability status using
Pearson's chi-square tests. To explore the association of disability
status and severity of disability with the risk of COVID-19, multi-
variable conditional logistic regression was performed after
adjusting for household income and comorbidities. Second, among
participants with COVID-19, Pearson's chi-square tests were used to
compare sociodemographic and clinical characteristics with
respect to disability status. To examine the association of disability
status and the severity of the disability with the major adverse
clinical outcomes from COVID-19, this study used multivariable
conditional logistic regression models after adjusting for sex, age,
residential area, household income, and comorbidities.
All data extraction and statistical analyses were performed us-
ing SAS v9.4 (SAS Institute Inc., Cary, NC). The Yonsei University
Institutional Review Board approved this study (approval number:
7001988-202010-HR-1016-01 E).
Results
The general characteristics of the study participants according
to COVID-19 status and major adverse clinical outcomes are shown
in Tables 1 and 2. Table 1 shows that the proportion of PwDs was
higher among people with COVID-19 than among those without
COVID-19 (7.7% vs. 5.5%). Table 2 shows that the proportion of PwDs
was substantially higher among people with major adverse out-
comes than among those without major adverse outcomes (23.9%
vs. 6.6%).
Sociodemographic and clinical characteristics according to
disability status are presented in Table 3. This study identified 7261
PwDs and 121,859 people without disabilities. The proportions of
men; older adults (60 years); individuals living in regions other
than Daegu and Gyeongbuk; individuals with low household in-
come; and individuals with certain medical conditions, including
diabetes mellitus, hypertension, dyslipidemia, ischemic heart dis-
ease, chronic obstructive pulmonary disease, chronic kidney dis-
ease, cancer, asthma, mental illness, and chronic liver disease, were
significantly higher among PwDs than among people without
Table 1
General characteristics of study participants according to COVID-19 status.
Variables Total With COVID-19 Without COVID-19 p-value
N % N %
Total 129,120 8070 6.3 121,050 93.8
Men 51,776 3236 40.1 48,540 40.1 1.000
Age group (years) 1.000
0e9 1296 81 1.0 1215 1.0
10e19 4416 276 3.4 4140 3.4
20e29 32,912 2057 25.5 30,855 25.5
30e39 13,312 832 10.3 12,480 10.3
40e49 16,576 1036 12.8 15,540 12.8
50e59 25,072 1567 19.4 23,505 19.4
60e69 19,184 1199 14.9 17,985 14.9




84,224 5264 65.2 78,960 65.2




31,769 2401 29.8 29,368 24.3
Second quantile 19,140 1101 13.6 18,039 14.9
Third quantile 21,829 1311 16.2 20,518 17.0
Fourth quantile 24,289 1348 16.7 22,941 19.0
Fifth quantile
(highest)
32,093 1909 23.7 30,184 24.9
Disability status <0.001
Yes 7261 619 7.7 6642 5.5
No 121,859 7451 92.3 114,408 94.5
Comorbidities
Diabetes mellitus 17,288 1185 14.7 16,103 13.3 <0.001
Hypertension 26,716 1662 20.6 25,054 20.7 0.826
Dyslipidemia 35,702 2268 28.1 33,434 27.6 0.347
Ischemic heart
disease
5818 399 4.9 5419 4.5 0.050
Stroke 3525 266 3.3 3259 2.7 0.001
Chronic obstructive
pulmonary disease
1717 136 1.7 1581 1.3 0.004
Chronic kidney
disease
1467 80 1.0 1387 1.1 0.205
Cancer 5764 361 4.5 5403 4.5 0.967
Asthma 14,258 953 11.8 13,305 11.0 0.023
Mental illness 26,176 1928 23.9 24,248 20.0 <0.001
Chronic liver disease 23,054 1500 18.6 21,554 17.8 0.076
Abbreviations: COVID-19, coronavirus disease.
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The general characteristics of the study participants who tested
positive for SARS-CoV-2 are shown according to disability status in
Table 4, and 7.7% among them had disabilities. The proportions of
men, young or middle-aged adults (59 years); those living in re-
gions other than Daegu and Gyeongbuk; and those with low
household income, diabetes mellitus, hypertension, dyslipidemia,
ischemic heart disease, chronic obstructive pulmonary disease,
chronic kidney disease, asthma, mental illness, or chronic liver
disease among PwDs were significantly higher than those among
people without disabilities.
Fig. 1 shows the association between disability status and risk of
SARS-CoV-2 test positivity. After adjusting for potential con-
founders, PwDs (odds ratio [OR]: 1.36, 95% confidence interval [CI]:
1.24e1.48) had a higher risk of SARS-CoV-2 test positivity than
those without disabilities. People with severe disability (OR: 1.82,
95% CI: 1.60e2.07) had a higher risk of SARS-CoV-2 test positivity
than those without disabilities; however, there was no significant
association between mild disability and the risk of SARS-CoV-2 test
positivity compared with no disability (OR: 1.05, 95% CI: 0.92e1.18).
Fig. 2 shows the association between disability status and the
risk of major adverse clinical outcomes of COVID-19 among patients
who tested positive for SARS-CoV-2. After adjusting for potential3
confounding factors, PwDs (OR: 1.43, 95% CI: 1.11e1.86) were
associated with an increased risk of major adverse clinical out-
comes of COVID-19 compared with people without disabilities.
People with severe disability (OR: 1.60, 95% CI: 1.12e2.31) were
associated with an increased risk of major adverse clinical out-
comes of COVID-19 compared with people without disabilities;
however, there was no significant association between mild
disability and the risk of major adverse clinical outcomes of COVID-
19 compared with no disability (OR: 1.29, 95% CI: 0.93e1.78).
Discussion
This nationwide study found that PwDs had an increased risk of
SARS-CoV-2 test positivity compared with those without disabil-
ities. Among people who tested positive for SARS-CoV-2, PwDs had
a higher risk of major adverse clinical outcomes of COVID-19 than
those without disabilities. People with severe disabilities had a
higher risk of COVID-19 and major adverse clinical outcomes than
those without disabilities; however, there was no significant as-
sociation between mild disability and the risk of COVID-19.
There are several possible explanations for the increased risk of
COVID-19 observed among PwDs. First, PwDs may have difficulty
practicing routine prevention behaviors (e.g., washing hands and
Table 2
General characteristics of patients with COVID-19 according to major adverse clinical outcomes.





N % N %
Total 8070 507 6.3 7563 93.7
Men 3236 281 55.4 2955 39.1 <0.001
Age group (years) <0.001
20e59 5849 108 21.3 5741 75.9
60 2221 399 78.7 1822 24.1
Residential area <0.001
Daegu and Gyeongbuk 5264 285 56.2 4979 65.8
Other regions 2806 222 43.8 2584 34.2
Household income <0.001
First quantile (lowest) 2401 165 32.5 2236 29.6
Second quantile 1101 37 7.3 1064 14.1
Third quantile 1311 77 15.2 1234 16.3
Fourth quantile 1348 80 15.8 1268 16.8
Fifth quantile (highest) 1909 148 29.2 1761 23.3
Disability status <0.001
Yes 619 121 23.9 498 6.6
No 7451 386 76.1 7065 93.4
Comorbidities
Diabetes mellitus 1185 216 42.6 969 12.8 <0.001
Hypertension 1662 308 60.7 1354 17.9 <0.001
Dyslipidemia 2268 291 57.4 1977 26.1 <0.001
Ischemic heart disease 399 78 15.4 321 4.2 <0.001
Stroke 266 68 13.4 198 2.6 <0.001
Chronic obstructive
pulmonary disease
136 41 8.1 95 1.3 <0.001
Chronic kidney disease 80 27 5.3 53 0.7 <0.001
Cancer 361 55 10.8 306 4.0 <0.001
Asthma 953 104 20.5 849 11.2 <0.001
Mental illness 1928 286 56.4 1642 21.7 <0.001
Chronic liver disease 1500 153 30.2 1347 17.8 <0.001
The major adverse clinical outcomes of COVID-19 comprised admission to the intensive care unit, invasive ventilation, or death.
Table 3
Characteristics of study participants according to disability status.
Variables Total People with disabilities People without disabilities p-value
N % N %
Total 129,120 7261 5.6 121,859 94.4
Men 51,776 3688 50.8 48,088 39.5 <0.001
Age group (years) <0.001
0e9 1296 14 0.2 1282 1.1
10e19 4416 52 0.7 4364 3.6
20e29 32,912 458 6.3 32,454 26.6
30e39 13,312 241 3.3 13,071 10.7
40e49 16,576 455 6.3 16,121 13.2
50e59 25,072 1239 17.1 23,833 19.6
60e69 19,184 1670 23.0 17,514 14.4
70 16,352 3132 43.1 13,220 10.8
Residential area 0.003
Daegu and Gyeongbuk 84,224 4618 63.6 79,606 65.3
Other regions 44,896 2643 36.4 42,253 34.7
Household income <0.001
First quintile (lowest) 31,769 2760 38.0 29,009 23.8
Second quintile 19,140 669 9.2 18,471 15.2
Third quintile 21,829 919 12.7 20,910 17.2
Fourth quintile 24,289 1108 15.3 23,181 19.0
Fifth quintile (highest) 32,093 1805 24.9 30,288 24.9
Comorbidities
Diabetes mellitus 17,288 2461 33.9 14,827 12.2 <0.001
Hypertension 26,716 3788 52.2 22,928 18.8 <0.001
Dyslipidemia 35,702 3986 54.9 31,716 26.0 <0.001
Ischemic heart disease 5818 1028 14.2 4790 3.9 <0.001
Stroke 3525 1041 14.3 2484 2.0 <0.001
Chronic obstructive pulmonary disease 1717 380 5.2 1337 1.1 <0.001
Chronic kidney disease 1467 496 6.8 971 0.8 <0.001
Cancer 5764 612 8.4 5152 4.2 <0.001
Asthma 14,258 1258 17.3 13,000 10.7 <0.001
Mental illness 26,176 3705 51.0 22,471 18.4 <0.001
Chronic liver disease 23,054 2440 33.6 20,614 16.9 <0.001
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Table 4
Characteristics of patients with COVID-19 according to disability status.
Variables Total People with disabilities People without disabilities p-value
N % N %
Total 8070 619 7.7 7451 92.3
Men 3236 333 53.8 2903 39.0 <0.001
Age group (years) <0.001
20e59 2058 228 36.8 1830 24.6




5264 376 60.7 4888 65.6
Other regions 2806 243 39.3 2563 34.4
Household income <0.001
First quintile (lowest) 2401 352 56.9 2049 27.5
Second quintile 1101 36 5.8 1065 14.3
Third quintile 1311 51 8.2 1260 16.9
Fourth quintile 1348 70 11.3 1278 17.2
Fifth quintile (highest) 1909 110 17.8 1799 24.1
Comorbidities
Diabetes mellitus 1185 215 34.7 970 13.0 <0.001
Hypertension 1662 319 51.5 1343 18.0 <0.001
Dyslipidemia 2268 347 56.1 1921 25.8 <0.001
Ischemic heart disease 399 73 11.8 326 4.4 <0.001
Stroke 266 106 17.1 160 2.1 <0.001
Chronic obstructive
pulmonary disease
136 34 5.5 102 1.4 <0.001
Chronic kidney
disease
80 35 5.7 45 0.6 <0.001
Cancer 361 30 4.8 331 4.4 0.640
Asthma 953 99 16.0 854 11.5 0.001
Mental illness 1928 396 64.0 1532 20.6 <0.001
Chronic liver disease 1500 195 31.5 1305 17.5 <0.001
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especially those relying on assistance with personal care. A previ-
ous study showed that thosewith disabilities were significantly less
likely than those without any disability to report frequent hand-
washing and surface disinfection.20 PwDs also have inequities in
access to public healthmessaging, possiblymaking their preventive
actions for COVID-19 difficult. A previous study showed that PwDs
felt that relevant health information is provided in a fragmentaryFig. 1. Association between disability status and the risk of SARS-CoV-2 test positivity.
The OR and 95% CI were calculated after adjusting for household income and comorbiditie
Abbreviations: OR, odds ratio; CI, confidence interval; SARS-CoV-2, severe acute respiratory
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manner through several channels that have relatively low reli-
ability.21 Second, PwDs may have limited access to healthcare ser-
vices.22 A study showed that most PwDs were affected by a lack of
access to facilities and equipment after COVID-19.23 Finally, PwDs
have more chronic medical conditions, as evidenced by the data in
this study (higher prevalence of chronic diseases in PwDs
compared to people without disabilities). These characteristics may
be associated with an increased risk of COVID-19 and worses.
syndrome coronavirus 2.
Fig. 2. Association between disability status and the risk of major adverse clinical outcomes among participants who tested positive for SARS-CoV-2
The major adverse clinical outcomes of COVID-19 comprised admission to the intensive care unit, invasive ventilation, or death. The OR and 95% CI were calculated after adjusting
for sex, age, residential area, household income, and comorbidities.
Abbreviations: OR, odds ratio; CI, confidence interval; MACOs, major adverse clinical outcomes; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; COVID-19, coro-
navirus disease.
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This study suggests that the preparedness and response plan-
ning of COVID-19 must be inclusive of and accessible to PwDs by
recognizing and addressing their challenges.4,25,26 Information on
COVID-19 should be conveyed using formats accessible to people
with specific types of disabilities, such as those who are blind, deaf,
and have intellectual impairment. Additionally, strategies for vital
in-person communication, such as sign language interpreters and
wearing of transparent masks by healthcare providers to allow lip-
reading, must be safe and accessible.
For PwDs with COVID-19, access to healthcare facilities,
including hospitals, needs to be strengthened so that they can
receive appropriate treatment for their underlying diseases, which
predispose them to poorer outcomes of COVID-19. If there are no
family members who can help PwDs with COVID-19, support from
care workers should be provided to enable them to access health-
care services. At a policy level, the responsible authorities should
give high priority and budgetary support to measures designed to
reduce the risk of COVID-19 among PwDs. Healthcare staff should
also be provided with rapid awareness training on the rights and
diverse needs of PwDs and the need to maintain their dignity,
safeguard against discrimination, and prevent inequities in care
provision.
This study showed that severe disability was associated with an
increased risk of COVID-19, but there was no significant association
with mild disability. People with severe disability have a higher
level of physical or mental functional impairment than those with
mild disability, and they may experience more barriers during the
COVID-19 pandemic, implying the need for specific measures for
those with severe disability.27
This study had some limitations. First, this study did not adjust
for some potential confounding factors, such as obesity, which may
have affected the response to SARS-CoV-2 infection.28 Further
studies that consider additional risk factors for COVID-19 are
required. Second, this study did not determine the association be-
tween the type of disability (e.g., vision, hearing, and intellectual
disability) and the risk of COVID-19 because of the data de-6
identification policy of the NHIS. Further study is needed to
investigate the risk of COVID-19 according to disability type. Finally,
this study was conducted only in South Korea; therefore, further
studies are warranted to explore the associations between
disability and risk of COVID-19 in other populations and countries.Conclusions
This large nationwide study found that PwDs were associated
with an increased risk of SARS-CoV-2 test positivity compared with
people without disabilities. Among patients who tested positive for
SARS-CoV-2, PwDs were associated with an increased risk of major
adverse clinical outcomes of COVID-19 compared with people
without disabilities. This study suggests that PwDs should be
included in the COVID-19 vaccination priorities. This study suggests
that further research on the causes of high risk of COVID-19 among
PwDs is required to create evidence for addressing their challenges.Funding
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